In addition, other emerging biomarkers-such as proadrenomedullin [30], soluble urokinase plasminogen activator receptor [31], and interleukin-6 [32] may provide insight into the severity of infection, immune dysregulation, or endothelial dysfunction and warrant further investigation. This evidence concerns the gene IL6 and endothelial dysfunction.